ZYRTEC
Pronunciation: se-TI-ra-zeen


What it isSecond-generation H1 antagonist; allergic rhinitis and urticaria.
Why it mattersAmong OTC second-generation agents, it is especially effective for urticaria but more likely to cause drowsiness.
What it changesReduce in renal impairment and warn about driving until sedation is known; alcohol and other sedatives add impairment.
Animated chart of estimated U.S. prescriptions per year, H1 antihistamines (1944–2026). Cetirizine enters in 1996 (estimated).
Principal riskSedation, more than loratadine
Legacy pregnancy categoryB
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Allergy symptoms | Adult & children >=6 yr | 10 mg QD | 10 mg QD (5 mg may suffice for milder symptoms) | 10 mg/24h |
Renal Undefined
Hepatic Undefined
Available strengths
Pregnancy Undefined
Lactation Undefined
Generic entry2007
Open Cetirizine in the interactive console ↗

Open Cetirizine in the interactive console ↗